The Covid-19 Early Treatment Fund was launched to provide funding for research in order to "find an existing drug or drug combination that, when given early, reduces hospitalization…
In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
NEW YORK (Reuters Health) – Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation and now new research shows that it can be performed…
NEW YORK (Reuters Health) – Deferring percutaneous coronary intervention (PCI) and treating high-risk heart disease patients with optimal medical therapy alone does not increase the risk of death,…
NEW YORK (Reuters Health) – While minimally invasive radical prostatectomy (MIRP) offers certain advantages over open retropubic radical prostatectomy (RRP), such as a shorter hospital stay, it also…
NEW YORK (Reuters Health) – Premenopausal women with vitamin D deficiency are at increased risk for systolic hypertension in the coming years, according to study findings presented Thursday…
NEW YORK (Reuters Health) – Women who undergo vaginal hysterectomy and reconstructive pelvic surgery during the same operation are more likely to have perioperative complications than those who…
NEW YORK (Reuters Health) – New research indicates that over half of men who choose watchful waiting as the initial strategy for prostate cancer require no treatment on…
NEW YORK (Reuters Health) – In older patients with stable coronary disease, adding percutaneous coronary intervention (PCI) to optimal medical therapy neither improves nor worsens their outcomes, new…
NEW YORK (Reuters Health) – During the 2007-2008 flu season, the licensed inactivated flu vaccine was 50% more effective than the live attenuated vaccine in preventing laboratory-confirmed symptomatic…
NEW YORK (Reuters Health) – Postmenopausal breast cancer patients taking aromatase inhibitors have increased risks for carpal tunnel syndrome and new or worsening arthralgia, two studies published online…
